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ORIGINAL ARTICLE
Background/Aims: Gastrointestinal (GI) symptoms are common among patients with non-insulin dependent
diabetes mellitus (NIDDM). Our aim was to investigate the frequency of chronic GI symptoms in Korean patients
with NIDDM.
Methods: A cross-sectional survey, using a reliable and valid questionnaire, was performed in diabetes clinics
from seven hospitals of the Catholic University of Korea. 
Results: A total of 608 patients (249 males and 359 females, mean age 53.7±10.9 years) were investigated. The
frequencies of weekly heartburn and acid regurgitation (esophageal symptoms) were 7.1% (95% confidence
interval [CI], 5.0 to 9.2) and 4.4% (95% CI, 2.8 to 6.1), respectively. The frequency of dyspepsia was 13.2%
(95% CI, 10.5 to 15.8). The frequencies of constipation and diarrhea were 15.0% (95% CI, 12.2 to 18.0) and
5.3% (95% CI, 3.5 to 7.1), respectively. Nausea and the use of manual maneuvers to facilitate defecation were
more prevalent in women than in men. Constipation and fecal incontinence were more common in diabetes
patients with long duration (>10 years). Fecal incontinence and using laxatives were more frequent in the
complicated diabetes group. Using laxatives was more frequent in the uncontrolled diabetes group. 
Conclusions: Two-thirds of diabetic patients experienced GI symptoms. The prevalence of GI symptoms was
more common in patients who had diabetic complications and a long duration of diabetes. (Korean J Intern Med
2009;24:309-317)
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INTRODUCTION
Diabetes mellitus is a systemic disease provoking
several complications such as retinopathy, nephropathy,
and neuropathy. Patients with diabetes have many
gastrointestinal (GI) symptoms because hyperglycemia
and neuropathy affect GI motility. Seventy-six percent
of outpatients have been reported to show one or more GI
symptoms [1] and 50-55% of patients with diabetes to
have upper GI symptoms [2,3]. However, Maser et al. [4]
suggested much lower prevalence rates for GI symptoms
in patients with diabetes. The reported prevalence rates
in these patients could differ, however, due to differences
in subject selection and survey methodology [5-7].
Although active studies on diabetes complications
performed in Korea have provided physicians with sufficient
information, research on GI symptoms in patients with
diabetes is scarce. The aim of this study was to investigate
GI symptoms in these patients visiting hospitals using a
validated questionnaire. METHODS
Subjects
This study recruited patients with non-insulin-
dependent diabetes mellitus (NIDDM) who visited the
Catholic University of Korea, School of Medicine, including
the Catholic Medical Center, Seoul St. Mary’s Hospital,
Holy Family Hospital, Daejeon St. Mary’s Hospital, St.
Vincent’s Hospital, Incheon St. Mary’s Hospital, or
Uijeongbu St. Mary’s Hospital (three in Seoul, two in
Gyeonggy-do, one in Incheon, and one in Daejeon) as
outpatients or inpatients for 4 weeks since June 1999.
Based on the numbers of outpatients at each hospital,
120 subjects each were identified from the Catholic
Medical Center, Seoul St. Mary’s Hospital, and Holy Family
Hospital, and 60 subjects each were identified from
Daejeon St. Mary’s Hospital, St. Vincent’s Hospital,
Incheon St. Mary’s Hospital, and Uijeongbu St. Mary’s
Hospital. The subjects were men and women aged 18 and
older who had been diagnosed with NIDDM prior to this
survey. General exclusion criteria were the following:
insulin-dependent diabetes mellitus; pregnant or breast-
feeding women; subtotal gastrectomy or a GI operation
including resection of the small or large intestine (although
a patient undergoing an appendicitis surgery without
complications was included in this study); serious cardio-
vascular, kidney, liver, lung, GI, endocrine, and metabolic
disorders or neural/mental disorders; and foreigners and
persons who could not answer the questionnaire due to
physical or psychological problems.
All patients with NIDDM visiting the hospitals during
the survey period were examined continuously through
interviews. The interviewers for the survey were trained at
meetings, and they assisted the elderly or patients who
could not understand the questions fully. 
Questionnaire
We assessed the GI symptoms of patients with diabetes
using “The GI symptom Questionnaire,” which was
designed by our department of gastroenterology. The
questionnaire had a total of 150 questions, including 140
questions based on the Rome I criteria of GI diseases
published in 1991 and 10 related to diabetes. The question-
naire was composed of 107 questions about GI symptoms
and 32 about lifestyle, social activities, history of disease,
visits to a hospital or clinic, and medications. Other psycho-
logical and physical symptoms were used to investigate
the definition, frequency, strength, and patterns of GI
symptoms. The validity of this questionnaire had been
demonstrated in a GI symptom study in patients visiting
hospitals and in local residents [8,9]. The remaining 10
questions were related to diabetes and specifically asked
about disease duration, glucose monitoring, treatment,
and diabetic complications. 
Standards for the GI symptoms
GI symptoms were determined based on chronic or
repeated symptoms over the past 12 months by considering
the international working team criteria (Rome I) [10]
defined below.
Upper GI symptoms: Upper GI symptoms were divided
according to frequency and degree as follows: globus
sense: unpleasant awareness of food bolus or feeling
that food sticks in the esophagus at least once per week;
heartburn: water brash regurgitated into the chest causing
a feeling of tightening or a burning or painful sensation
one or more times weekly for the last year; reflux: water
brash or bitter water regurgitated into the mouth one or
more times per week; rumination: undigested food regur-
gitated into the mouth (distinguished from vomiting)
during the last year; dyspepsia: epigastric pain or dis-
comfort at least six times during the last year;  nausea and
vomiting: nausea or vomiting one or more times a week;
early satiety: stomach frequently feels full just after
starting a meal, considering the amount of food consumed,
for at least 3 months; and abdominal distention: the
abdomen was tight for at least 3 months. 
Lower GI symptoms as follows: irritable bowel symptoms
(IBS) which were selected based on Rome I symptoms;
epigastric pain or discomfort occurred for at least 3 months
and was relieved by a bowel movement or was associated
with alternation of frequency or character of defecation;
constipation, two or fewer defecations per week, or the
stool was hard for more than one-third of the period in
question; diarrhea: three or more defecations per day, or
the stool was loose or watery for more than one- third of the
period in question; excessive straining during defecation:
straining was required during defecation for more than
one-third of the period in question; urgent defecation:
defecation was urgently required for more than one-third
of the period in question; fecal incontinence: involuntary
defecation or leaking occurred during the last 1 year; other
symptoms, such as a feeling of incomplete evacuation, the
requirement for an activity promoting defecation, such as
hand massage, and the necessity of constipation drugs or
adjuvant treatments were also investigated. The frequency
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percentage, and the data were compared with a χ
2 test
according to gender, morbidity period, and complications.
Additionally, a 95% confidence interval (CI) was calculated.
RESULTS
Overview
In total, 608 patients with diabetes who visited seven
affiliated hospitals of the Catholic University of Korea
since June 1999 were investigated consecutively to reach
the number of subjects designated for each hospital; the
survey period was 2 weeks. The subjects were composed
of 249 men (40.9%) and 359 women (59.1%), and their
average age was 53.7±10.9 years (52.9±10.5 and 54.2±11.1
years for men and women, respectively). The average
morbidity period was 7.6±6.7 years. The sociodemographic
data are shown in Table 1. Subjects with at least one
defined complication (diabetic retinopathy, nephropathy,
or neuropathy) were considered to have a complication,
and 234 patients (45.3%) among 516 (84.9%) whose
complications were evaluated showed diabetic com-
plications. The average glycosylated hemoglobin (HbA1c)
was 8.1±2.1% (8.2±2.2% and 8.1 1.9% for men and
women, respectively), and no significant difference was
observed between the sexes. 
Prevalence of GI symptoms
Subjects who had experienced at least one chronic GI
symptom for the last year accounted for 69.6% of the total.
Among them, 155 (62.2%) men and 268 (74.7%) women
had GI symptoms, and the female patients showed a
significantly higher prevalence of chronic GI symptoms
than males (p=0.001). Except for regular visits for
glycemic control, 13.6% of patients had visited doctors for
GI symptoms (28 [11.2%] men and 55 [15.3%] women).
No significant difference was observed based on gender. 
Upper GI symptoms
Among the subjects, 7.1% (95% CI, 5.0 to 9.2) of men
and 4.4% (95% CI, 2.8 to 6.1) of women experienced
heartburn and reflux one or more times per week. When
gastroesophageal reflux disease (GERD) was diagnosed as
one or more episodes of reflux or heartburn per week, its
prevalence rate was 9.8%. The rate of dyspepsia was 9.2%
(95% CI, 6.9 to 11.6), and patients with dyspepsia included
9.6% of the men and 8.9% of the women. Among subjects
not included in the dyspepsia group, 34 (5.6%), 6 (1.0%),
and 80 (13.2%) took H2 receptor antagonists, proton
pump inhibitors, and prokinetics, respectively, when the
survey was conducted. Overall, 106 (17.4%) patients took
at least one of the drugs. In addition, 6.7% (95% CI, 4.7 to
8.8) experienced one or more episodes of nausea per
week, and the frequency of female nausea was higher than
that of males (8.6% and 4.0%, respectively, p<0.05).
Patients who vomited one or more times per week
comprised 1.6% (95% CI, 0.6 to 2.7), and 11.2% (95% CI,
8.6 to 13.7) experienced early satiety and abdominal
distention (Table 2). 
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Table 1. The Characteristics of patients with non-insulin dependent diabetic mellitus
Men Women Total
(n=249) (n=359) (n=608)
Age, yr 52.9±10.5 54.2±11.1 53.7±10.9
Body mass index, kg/m
2 22.9±2.9 23.9±3.4 23.5±3.3
Smoker 172 (69.1)* 26 (7.2) 198 (32.6)
Alcohol drinker 131 (52.6)* 38 (10.6) 169 (27.8)
Duration of diabetes, yr  7.1±6.7 8.0±6.7 7.6±6.7
Fasting glucose, mg/dL 150.7±55.4 158.5±60.2 155.2±58.3
HbA1c, % 8.2±2.2 8.1±1.9 8.1±2.1
Treatment of diabetes, %
Diet control 6.8 4.7 5.4
Oral medication 56.8 60.7 59.1
Insulin 36.4 34.5 35.3
Data are presented as mean±SD or number (%).
*p<0.001 vs. female. Lower GI symptoms
In total, 6.4% (95% CI, 4.4 to 8.4) of the subjects had
symptoms diagnosed as IBS. As the rate among men and
women was 5.6% and 7.0%, respectively, no significant
gender difference was detected in IBS. Constipation was
experienced by 15.0% (95% CI, 12.2 to 18.0), and 16.0%
(95% CI, 13.0 to 18.9) used constipation drugs or adjuvant
therapies. Patients who were helped by hand massage
during defecation included 6.0% of the men and 11.4% of
the women (p<0.05). Diarrhea was found in 5.3% (95%
CI, 3.5 to 7.1) of subjects, and fecal incontinence was found
in 11.2% (95% CI, 8.6 to 13.7). Other lower GI symptoms are
shown in Table 3. 
Correlation between clinical characteristics and
prevalence of GI symptoms
Prevalence of GI symptoms according to gender
The prevalence of esophageal symptoms, dyspepsia,
early satiety, and abdominal distention was not signifi-
cantly different according to gender, and only nausea
occurred more commonly in women than men (p<0.05).
While constipation, diarrhea, fecal incontinence, and
administration of constipation drugs were not different
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Table 2. Prevalence of upper gastrointestinal symptoms in patients with non-insulin dependent diabetic mellitus
Symptoms Men Women Overall [95% confidence interval]
(n=249) (n=359)
Globus 10 (4.0) 18 (5.0) 28 (4.6) [2.9-6.3]
Rumination 12 (4.8) 17 (4.7) 29 (4.8) [3.0-6.5]
Heartburn 16 (6.4) 27 (7.5) 43 (7.1) [5.0-9.2]
Acid regurgitation 10 (4.0) 17 (4.7)  27 (4.4) [2.8-6.1]
Nausea 10 (4.0) 31 (8.6)* 41 (6.7) [4.7-8.8]
Vomiting 3 (1.2) 7 (1.9) 10 (1.6) [0.6-2.7]
Early satiety 22 (8.8) 46 (12.8) 68 (11.2) [8.6-13.7]
Bloating 23 (9.2) 45 (12.5) 68 (11.2) [8.6-13.7]
Dyspepsia 34 (13.7) 46 (12.8) 80 (13.2) [10.5-15.8]
Data are presented as number (%).
*p<0.05 vs. male. 
Table 3. Prevalence of lower gastrointestinal symptoms in patients with non-insulin dependent diabetic mellitus
Symptoms Men Women Overall [95% confidence interval]
(n=249) (n=359)
IBS by Rome criteria 14 (5.6)                25 (7.0) 39 (6.4) [4.4-8.4]
Constipation (a) and/or (b) 33 (13.3) 59 (16.4) 92 (15.0) [12.2-18.0]
(a) ≤2 stools/wk  14 (5.6) 31 (8.6) 45 (7.4) [5.3-9.5]
(b) Hard stool† 26 (10.4) 42 (11.7) 68 (11.2) [8.6-13.7]
Diarrhea (a) and/or (b) 16 (6.4) 16 (4.5) 32 (5.3) [3.5-7.1]
(a) ≥3 stools/day 6 (2.4) 3 (0.8) 9 (1.5) [0.5-2.5]
(b) Watery stool† 15 (6.0) 15 (4.2) 30 (4.9) [3.2-6.7]
Straining at defecation 80 (32.1) 132 (36.8) 212 (34.9) [31.0-38.7]
Feeling of incomplete evacuation 105 (42.2) 141 (39.3) 246 (40.5) [36.5-44.4]
Manual maneuvers to facilitate 15 (6.0) 41 (11.4)* 56 (9.2) [6.9-11.6]
Urgency to defecate 7 (2.8) 18 (5.0) 25 (4.1) [2.5-5.7]
Fecal incontinence 27 (10.8) 41 (11.4) 68 (11.2) [8.6-13.7]
Using laxatives 42 (16.9) 55 (15.3) 97 (16.0) [13.0-18.9]
Data are presented as number (%).
IBS, irritable bowel syndrome.
*p<0.05 vs. male.
†More than 1/3 of the time.between the sexes, among the symptoms related to
defecation, women required more activities for promoting
defecation, such as hand massage (p<0.05). 
Prevalence of GI symptoms according to the
morbidity period
To evaluate the prevalence rates of GI symptoms
according to morbidity period of diabetes, the subjects
were divided into a 10 years or less morbidity group
(n=443) and a greater than 10 years morbidity group
(n=138), and the rates of GI symptoms in the two groups
were compared (Table 4). No significant differences were
observed in the upper GI symptom prevalence rates based
on the morbidity period. Among lower GI symptoms,
patients with two or fewer defecations (p<0.05), those
with hard stools for more than one-third of the period in
question (p<0.01), and those with constipation (p<0.001)
who met one of these two criteria were more common in
the more than 10-year group than in the less than 10-year
group. Subjects with fecal incontinence were also more
commonly found in the group with the longer morbidity
period (p<0.05). 
Prevalence of GI symptoms according to
complications 
The frequencies of fecal incontinence symptoms and the
administration of constipation drugs were higher in the
complication group than in the non-complication group
(p<0.05), but the frequencies of other GI symptoms were
not significantly different between the two groups (Table 4). 
Prevalence of GI symptoms according to sugar
control
Among the 510 subjects whose HbA1c was examined,
when the subjects were divided into an uncontrolled blood
sugar group having an 8% or higher HbA1c level and an
controlled sugar group, 282 (55.3%) patients were included
in the uncontrolled sugar group. The prevalence rates of
GI symptoms in the two groups were compared, and the
frequency of using constipation drugs or adjuvant therapies
Oh JH, et al. The prevalence of GI symptoms in patients with NIDDM    313
Table 4. Prevalence of main gastrointestinal symptoms according to duration of diabetes, presence of diabetic
complications, and blood sugar control
Symptoms Duration Complication Blood sugar control
≤10 yr >10 yr No Yes Good Poor
(n=443) (n=138) (n=282) (n=234) (n=282) (n=228)
Heartburn 2.7 1.4 1.4 2.6 7.8 7.0
Acid regurgitation 2.0 0.7 2.1 0.4 3.5 3.5
Nausea 6.8 6.5 5.3 9.0 6.0 7.5
Vomiting 1.4 2.9 0.7 3.4 1.8 1.8
Early satiety 10.6 12.3 8.5 14.1 9.2 10.5
Bloating 11.1 11.6 10.3 12.0 11.3 12.3
Abdominal pain or discomfort 9.9 6.5 7.8 10.7 12.1 14.9
Constipation (a) and/or (b) 11.1  26.1† 13.1 19.7 12.4 17.1
(a) ≤2 stools/wk 5.9 11.6‡ 7.1 9.0 6.4 8.4
(b) Hard stool* 7.9 23.9§ 10.3 14.5 9.6 12.3
Diarrhea (a) and/or (b) 5.6 4.3 6.4 4.3 5.0 5.7
(a) ≤3 stools/day  1.6 0.7 1.1 1.7 1.4 1.8
(b) Watery stool* 5.4 3.6 6.0 3.8 4.6 5.3
Fecal incontinence 9.9 17.4‡ 8.2 17.5§ 9.6 13.6
Using laxatives 9.5 15.2 8.9 15.8‡ 8.5 14.5‡
Consulted doctor for  12.6 19.6 12.8 13.7 14.9 13.2
GI symptoms
Data are presented as percentage. 
*More than 1/3 of the time.
†p<0.01.
‡p<0.05.
§p<0.001.was higher in the uncontrolled sugar group, whereas the
frequencies of other symptoms were not significantly
different between the two groups (Table 4). 
DISCUSSION
This study investigated the prevalence of GI symptoms
continuously in patients with diabetes for a short period of
time at seven hospitals located in Seoul, Incheon, Daejoen,
and Gyeonggy (selected to represent the whole country).
In total, 608 subjects were included and were composed
of 249 (41%) men and 359 (59%) women. Their ages were
less than 30, 30-39, 40-49, 50-59, 60-69, and 70 or older
in 3.6%, 7.6%, 19.1%, 37.5%, 28.5%, and 3.8% of the
subjects, respectively, and the age distribution was similar
to that of the national survey on the prevalence of diabetes
[11]. The national survey was conducted with 146,944
Korean adults, and it reported that the prevalence rates
of diabetes in males and females were 4.6% and 8.1%,
respectively. In this study, the subjects’ body mass index
(BMI) and HbA1c level were 23.5±3.25 kg/m
2 (men,
22.9±2.93; women, 23.9±3.41) and 8.1±2.1%, respectively,
and they did not differ from those of patients with NIDDM
in other surveys reported in Korea (22.7-24.6 kg/m
2 and
7.54-9.12%, respectively) [12,13]. The BMI of patients with
NIDDM in the West and in Hong Kong [14] were reported
to be 28.0-30.3 kg/m
2 and 24.7±4.1 kg/m
2, respectively,
and those of Western subjects were higher than those of
this study, whereas those of Hong Kong subjects were not
different from those found in this study. 
The gender, age distribution, and clinical characteristics
of the subjects in this study were similar to those in other
studies on diabetes prevalence in Korea. Although this
study was not a sample survey representing all patients
with NIDDM in Korea, its results are considered meaningful
because we continuously investigated patients visiting
the second or the third hospitals in various regions of the
country.
When the results of this study were compared with
those of a survey conducted with Koreans in rural areas
[9], the frequencies of reflux, heartburn, dyspepsia, con-
stipation, and other symptoms were not significantly
different. This differed from the results of foreign research
[1-3], which found that patients with diabetes showed
more GI symptoms. In this study, women had more GI
symptoms, and this result was the same as that in studies
reporting that the prevalence rates of GI symptoms were
higher in females than males [6]. Although the frequencies
of alcohol consumption and smoking, which can increase
these symptoms, were higher in men than in women
(p<0.001), the result that women had more GI symptoms
could be explained by the fact that females in the general
population show higher rates of GI symptoms [15]. 
Among the esophageal disorder prevalence rates, the
rates of reflux and heartburn experienced one or more
times per week were 4.4% and 7.1%, respectively. The rate
of heartburn in this study was considerably lower than
that of Western patients with diabetes (25-31.7%) [7,16],
which was thought to be attributable to the rate of GERD
being lower in Asian countries compared to Western
countries. The rate of heartburn in the Hong Kong survey
(8.1%) was similar to that of this study, and the rates in
the Korean population in rural areas were also similar
with those of this study (6.9% and 5.2%, respectively). The
BMI values of patients with diabetes in this study and
in the Hong Kong survey were lower than the BMIs of
Western studies. While previous research [17] revealed
that the prevalence of GERD was higher in obese patients,
a recent study reported no correlation between obesity
and GERD [18]. Therefore, the effect of the difference in
BMI between the continents on the prevalence rates was
considered to be low. 
The nausea and vomiting prevalence rates among upper
GI symptoms were 6.7% and 1.6%, respectively. In a
survey performed in Finland [7] applying the same criteria
as this study, the prevalence of nausea was 17% and 18%
in males and females, respectively, and that of vomiting
was 5% and 6% in males and females, respectively.
Although the criteria were not different from those of this
study, other research [2,19] has reported that the prevalence
rates of nausea and vomiting were 16.8-21.0% and 5.6-
16.0%, respectively. The Hong Kong survey also found
that the prevalence of nausea or vomiting was 3.4%, and
that the rate of the diseases among patients with diabetes
in Asia was lower than in the West. Compared to a survey
conducted in the United States, the lower prevalence of
nausea, vomiting, early satiety, and abdominal distention
shown in this study was considered to be caused by the
decrease in symptoms due to a higher frequency of drug
administration, especially prokinetics, in Korean patients
(15.2%) compared to that in the U.S. survey (1.5%) [20]. As
the prevalence rates of early satiety and abdominal
distention were 32.2% and 21.0%, respectively, in the U.S.
sample survey [2], the U.S. levels were higher than those
of this study. The rates in the Hong Kong survey were
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The prevalence of dyspepsia in patients with diabetes in
this study was 13.2%, which was lower than that of
previous Western research reporting 15.1-28.3% (15.1-15.4%
in the U.S. sample survey, 27.1% in a Finnish survey, and
28.3% in a Swedish survey), a Chinese study reporting 16.1%,
and a Korean rural population study reporting 15.5%.
According to the results of analysis on administered drugs
and prescribed drugs, the prevalence of patients taking at
least one antacid or prokinetic, except for those patients
diagnosed with dyspepsia, was higher at 18.9%, and this
higher frequency of medication could have led to the
lower dyspepsia prevalence rate. If subjects taking drugs
were included, the prevalence of Korean patients with
diabetes would be 27.8% (95% CI, 24.2 to 31.4). 
Among lower GI symptoms, the prevalence of consti-
pation was 15.0%. The prevalence rates for the U.S.
sample survey [20], the European surveys, and the Hong
Kong survey were 10.0%, 13.1-22.1% (22.1% in a German
survey [5], 13.1% in a Swedish survey [6], and 20.4% in a
Finnish survey [7]), and 27.5%, respectively, indicating that
constipation was a very common GI symptom in patients
with diabetes. Therefore, the administration of constipation
drugs was investigated in most research. Patients with
diabetes taking constipation drugs in the U.S. sample
survey, the Finnish survey, and the Swedish survey were
15.1%, 7.5%, and 3.4%, respectively, and these frequencies
were higher compared to those of the general population
in all surveys. In this study, patients taking constipation
drugs were found frequently (16.0%), and the level was
also higher than that of the general Korean population
(10.5%) surveyed by our department [9]. This difference
was considered to follow the higher rate of constipation in
patients with diabetes and the higher likelihood of taking a
constipation drug. In previous studies on GI symptoms,
investigations of the administration of drugs, except
constipation drugs, have rarely been conducted. According
to research performed in the United States with a sample
population in Minnesota [20], administered drugs could
affect GI symptoms. In this research, the frequencies of
patients taking constipation drugs, antacids, acid sup-
pression drugs, and prokinetics were 15.9-17.0%, 10.9-
12.0%, 5.1-9.2%, and 1.5%, respectively, and those of the
nondiabetes control group were 10.0-14.7%, 21.2-23.9%,
7.1-13.8%, and 0.5%, respectively. Although only calcium
channel blockers were related to constipation among
these administered drugs, acid suppression drugs,
prokinetics, or others could induce changes in GI symp-
toms. Therefore, future studies on GI symptoms should be
conducted along with surveys on drug administration. The
rate of diarrhea in this study was 11.2%, and those in the
U.S. sample survey and European studies were 15.1% and
9.5-13.1% (9.5% in the Finnish survey and 13.1% in the
Swedish survey), respectively. Because the rate in the
Hong Kong survey was 34.9%, it was different from that of
this study. In other words, the prevalence rates of
constipation and diarrhea in Hong Kong and Korea were
considerably different, although both are Asian countries.
This difference was considered to occur because the Hong
Kong survey defined constipation and diarrhea subjec-
tively as difficulties during defecation and as increased
frequency of defecation along with a loose stool, respectively. 
To evaluate the effects of the diabetes morbidity period
on the occurrence of GI symptoms, subjects were divided
into a 10 year or greater morbidity group and a less than
10 year group, and the prevalence rates for constipation
and fecal incontinence were higher in the 10 years or
greater morbidity group. The Hong Kong survey [14] also
investigated the correlation between GI symptoms and
various diabetes-related factors through multivariate
analysis and revealed that only the diabetes morbidity
period was an independent variable related to the occur-
rence of GI symptoms in patients with diabetes. 
The prevalence rates of diabetes complications were
very different according to the definition and morbidity
period, as shown in the results that the rates of diabetic
neuropathy were 10-100% in foreign countries and 8.8-
78.1% in Korea [21]. Additionally, whether diabetes
complications increased the prevalence rates of GI
symptoms was answered differently according to different
studies [5,14,16,19,22-24]. While one study reported no
correlation between diabetic neuropathy and the
occurrence of GI symptoms and neuropathy being more
related to mental factors [19], other studies found that
among the diabetes complications, neuropathy was
related to the occurrence of GI symptoms [16,24]. Although
many studies have shown that diabetes complications
increase the prevalence of GI symptoms, the results were
different according to various factors, such as types of GI
symptoms and gender. According to the results of this
study, the frequencies of only the administration of consti-
pation drugs and fecal incontinence, among GI symptoms,
were higher in the complication group than in the non-
complication group. No difference in the frequencies of
other GI symptoms was observed according to the
existence of a complication, which was similar to that of a
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of heartburn in the complication group was lower than
that in the non-complication group, and Channer et al.
[23] showed that the frequencies of upper GI symptoms
were higher in patients who had diabetes with anatomic
neuropathy compared to the control group. While
neuropathy provokes GI symptoms by infiltrating into
motor nerves to induce GI dysmotility, if the disease
infiltrates into sensory nerves, it could result in serious
movement disorders without symptoms. Future studies
with more patients are needed to examine the association
between neuropathy and GI symptoms in patients with
diabetes. Whether the GI symptom prevalence rates
increase in an uncontrolled sugar group among such
patients has also yet to be decided [14,24,26]. This study
found, like other current studies, that sugar control did
not affect GI symptom occurrence [27]. Only the adminis-
tration of constipation drugs and adjuvant therapies, such
as enema, was observed more frequently in patients with
diabetes who had uncontrolled sugar levels.
The prevalence of diabetes has continued to increase,
and hospitalization, death, and complications following
the disease have grown to account for an important part of
the Korean public health condition. Nationwide research,
including samples of nondiabetic persons, on the clinical
patterns and complications of GI symptoms in diabetes as
a representative adult Korean disease is desperately
needed. 
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